| Cat. No. | Product Description | Application | Quantity | Price | Cart |
|---|---|---|---|---|---|
HS-460 008 | CD68, rabbit, monoclonal, recombinant IgGrecombinant IgG human specific | WB IHC-P (FFPE) | 100 µl | $420.00 |   |
| HS-460 017 | CD68, rat, monoclonal, purified IgG IgG human specific | WB ICC IHC IHC-P (FFPE) | 200 µl | $420.00 | |
| HS-492 003 | CD73, rabbit, polyclonal, affinity purifiedaffinity mouse specific | IHC IHC-P (FFPE) | 50 µg | $375.00 | |
| HS-466 003 | CD86, rabbit, polyclonal, affinity purifiedaffinity mouse specific | WB IHC IHC-P (FFPE) IHC-Fr | 50 µg | $375.00 | |
| HS-361 003 | CD8a, rabbit, polyclonal, affinity purifiedaffinity mouse specific | WB IHC IHC-P (FFPE) IHC-Fr | 200 µl | $380.00 | |
| HS-361 008 | CD8a, rabbit, monoclonal, recombinant IgGrecombinant IgG mouse specific | WB IHC-P (FFPE) | 100 µl | $420.00 | |
| HS-361 017 | CD8a, rat, monoclonal, purified IgG IgG mouse specific | WB IHC-P (FFPE) IHC-Fr | 200 µl | $420.00 | |
| 104 103 | Cellubrevin, rabbit, polyclonal, affinity purifiedaffinity K.O. | WB IP ICC IHC IHC-P (FFPE) EM | 50 µg | $460.00 | |
| 104-1P | Cellubrevin, control peptidecontrol peptide | 100 µg | $110.00 | | |
| 501-Cb | Cerebellum lysate, rat, tissue lysatetissue lysate | WB | 200 µg | $285.00 | |
| 414 004 | CGRP, Guinea pig, polyclonal, antiserumantiserum | ICC IHC IHC-P (FFPE) iDISCO Clarity | 100 µl | $370.00 | |
| 297 003 | ChAT, rabbit, polyclonal, affinity purifiedaffinity | WB | 50 µg | $380.00 | |
| 297 013 | ChAT, rabbit, polyclonal, affinity purifiedaffinity discontinued, replacement: 297 108 | WB IHC IHC-P (FFPE) | 50 µg | ||
| 297 015 | ChAT, Guinea pig, polyclonal, affinity purifiedaffinity discontinued, replacement: 297 308 | IHC IHC-P (FFPE) | 50 µg | ||
| 297 108 | ChAT, rabbit, monoclonal, recombinant IgGrecombinant IgG | ICC IHC IHC-P (FFPE) | 50 µg | $420.00 | |
Certificates
ISO 9001 2015 Quality Management System and Green Lab Platinum certification level for sustaining laboratory processes.
Newsletter
Sign up for our newsletter and get the latest updates and news.
